Nyxoah S.A. (NYXH )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol NYXH
- Company Nyxoah S.A.
- Price $1.39
- Changes Percentage -4.14
- Change -0.06
- Day Low $1.35
- Day High $1.68
- Year High $8.59
- Year Low $2.68
- Market Cap $107,178,342
- Price Avg 50 EMA (D) $3.06
- Price Avg 200 EMA (D) $4.48
- Exchange NASDAQ
- Volume 18,761
- Average Volume 44,593
- Open $1.67
- Previous Close $1.45
- EPS -2.49
- PE -1.15
- Earnings Announcement 2026-08-05 20:00:00
- Shares Outstanding $37,344,370
Company brief: NYXOAH S.A. (NYXH )
- Healthcare
- Medical - Instruments & Supplies
- Mr. Olivier Taelman
- https://www.nyxoah.com
- BE
- N/A
- 04-28-2021
- BE0974358906
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.